This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business partnership

Costco Sells Discounted Ozempic, Wegovy

Analysis based on 9 articles · First reported Oct 03, 2025 · Last updated Oct 06, 2025

Sentiment
50
Attention
6
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The partnership between Costco and Novo Nordisk is expected to positively impact both companies. Costco's move into discounted GLP-1 medications like Semaglutide and Semaglutide could attract new members and increase pharmacy sales, while Novo Nordisk benefits from expanded distribution and increased accessibility for its key products, potentially boosting revenue and market share. This also sets a competitive precedent for other retailers like Lewis Pharmacy, Walgreens, and Walmart.

Pharmaceuticals Retail Healthcare

Costco has partnered with Novo Nordisk to offer popular weight-loss and diabetes drugs, Semaglutide and Semaglutide, at a discounted price of $499 for a four-week supply through its pharmacies. This initiative, available to Costco members not using insurance, aims to improve access to these medications, which typically retail for much higher prices. The move is seen as a way to combat the high cost and limited insurance coverage that many Americans face when trying to obtain GLP-1 medications. David Moore of Novo Nordisk emphasized the importance of offering authentic medications through a trusted brand like Costco. While experts like Rekha Kumar and Harlan Krumholz acknowledge the improved access, they also highlight that the $499 price may still be prohibitive for lower socioeconomic strata and does not resolve broader issues of insurance coverage.

stock
Novo Nordisk partnered with Costco to expand access and sales of its GLP-1 medications, Semaglutide and Semaglutide, at a standardized discounted price, combating competition from compounding pharmacies.
Importance 95.0 Sentiment 70.0
stock
Costco partnered with Novo Nordisk to sell Semaglutide and Semaglutide at a discounted price, enhancing its pharmacy offerings and potentially increasing membership and sales.
Importance 90.0 Sentiment 60.0
per
David Moore, president of Novo Nordisk U.S., emphasized the company's desire to offer authentic medications through trusted brands like Costco.
Importance 20.0 Sentiment 0.0
stock
Walgreens is mentioned as offering Semaglutide and Semaglutide at the same out-of-pocket price as Novo Nordisk's direct program and Costco, highlighting the broader market for these drugs.
Importance 10.0 Sentiment 0.0
priv
Lewis Pharmacy is mentioned as also offering Semaglutide and Semaglutide at the same out-of-pocket price as Novo Nordisk's direct program and Costco, indicating a competitive pricing landscape.
Importance 10.0 Sentiment 0.0
stock
Walmart is mentioned as offering Semaglutide and Semaglutide at the same out-of-pocket price as Novo Nordisk's direct program and Costco, indicating a consistent pricing strategy across major retailers.
Importance 10.0 Sentiment 0.0
per
Dr. Rekha Kumar, an endocrinologist, praised the partnership for improving access to the medications but noted it doesn't solve insurance and cost issues.
Importance 5.0 Sentiment 0.0
per
Dr. Harlan Krumholz, a cardiologist, expressed concern that the $499 price is still too high for many who need the medications most.
Importance 5.0 Sentiment 0.0
subs
Costco Citigroup — Citibank credit card holders receive an additional 2% discount on Semaglutide and Semaglutide prescriptions.
Importance 5.0 Sentiment 0.0
cnt
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.